Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$351M |
| 2 |
Netflix
NFLX
|
+$343M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$293M |
| 4 |
Nike
NKE
|
+$186M |
| 5 |
Delta Air Lines
DAL
|
+$177M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$1.33B |
| 2 |
Tesla
TSLA
|
+$344M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$306M |
| 4 |
NVIDIA
NVDA
|
+$281M |
| 5 |
Boeing
BA
|
+$251M |
Sector Composition
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.45% |
| 3 | Consumer Discretionary | 12.35% |
| 4 | Consumer Staples | 10.15% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3051
iShares Russell Top 200 Value ETF
IWX
$2.82B
| $222K | ﹤0.01% |
3,400
-5,300
| -61% | -$346K |
|
3052
Sight Sciences
SGHT
$181M
| $222K | ﹤0.01% |
66,000
+50,700
| +331% | +$171K |
|
|
ICD
3053
DELISTED
Independence Contract Drilling, Inc.
ICD
| $222K | ﹤0.01% |
73,978
+2,134
| +3% | +$6.4K |
|
|
DOMA
3054
DELISTED
Doma Holdings, Inc.
DOMA
| $222K | ﹤0.01% |
43,707
-400
| -0.9% | -$2.03K |
|
3055
Vanguard S&P Mid-Cap 400 ETF
IVOO
$2.81B
| $220K | ﹤0.01% |
+2,600
| New | +$220K |
|
|
SILV
3056
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $220K | ﹤0.01% |
49,800
-188,341
| -79% | -$832K |
|
|
AFIB
3057
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| $220K | ﹤0.01% |
315,400
-54,500
| -15% | -$38K |
|
3058
Rimini Street
RMNI
$417M
| $219K | ﹤0.01% |
99,422
-35,508
| -26% | -$78.2K |
|
3059
Schwab US Large-Cap Value ETF
SCHV
$13.5B
| $219K | ﹤0.01% |
10,200
-18,000
| -64% | -$386K |
|
3060
SPDR Portfolio Long Term Corporate Bond ETF
SPLB
$918M
| $219K | ﹤0.01% |
+10,300
| New | +$219K |
|
3061
Vanguard Communication Services ETF
VOX
$5.89B
| $219K | ﹤0.01% |
2,084
-7,916
| -79% | -$832K |
|
3062
Equillium
EQ
$111M
| $217K | ﹤0.01% |
293,291
-98,940
| -25% | -$73.2K |
|
3063
Jasper Therapeutics
JSPR
$39.5M
| $217K | ﹤0.01% |
31,021
+25,211
| +434% | +$176K |
|
|
NCNA
3064
NuCana
NCNA
$7.37M
| $217K | ﹤0.01% |
71
-2
| -3% | -$6.11K |
|
3065
PureCycle Technologies
PCT
$2.4B
| $217K | ﹤0.01% |
+38,600
| New | +$217K |
|
3066
Karooooo
KARO
$1.69B
| $215K | ﹤0.01% |
+10,801
| New | +$215K |
|
3067
MVB Financial
MVBF
$305M
| $215K | ﹤0.01% |
+9,500
| New | +$215K |
|
3068
Cardiff Oncology
CRDF
$136M
| $214K | ﹤0.01% |
154,000
-157,290
| -51% | -$219K |
|
3069
Alerus Financial
ALRS
$577M
| $213K | ﹤0.01% |
11,700
-400
| -3% | -$7.28K |
|
|
SSY
3070
DELISTED
SunLink Health Systems
SSY
| $213K | ﹤0.01% |
266,478
-4,400
| -2% | -$3.52K |
|
|
BWAY
3071
Brainsway
BWAY
$298M
| $212K | ﹤0.01% |
52,500
+8,529
| +19% | +$34.4K |
|
3072
First Interstate BancSystem
FIBK
$3.43B
| $212K | ﹤0.01% |
+8,498
| New | +$212K |
|
3073
Nurix Therapeutics
NRIX
$691M
| $211K | ﹤0.01% |
+26,800
| New | +$211K |
|
3074
Simply Good Foods
SMPL
$2.73B
| $211K | ﹤0.01% |
+6,100
| New | +$211K |
|
3075
Q32 Bio
QTTB
$23.5M
| $211K | ﹤0.01% |
10,000
-6,617
| -40% | -$140K |
|